
Altavo is a medical device startup based in Dresden, Germany, focused on improving the lives of people who have lost their voice. They leverage machine learning and state-of-the-art sensor technology, specifically non-invasive silent speech technology, to enable individuals, particularly laryngectomy patients, to regain a natural-sounding voice. Their team comprises experts from diverse fields including AI, RF engineering, speech therapy, and regulatory affairs, all driven by a passion for creating impactful technologies that enhance patient quality of life. Altavo is collaborating with universities and has received grants from the State of Saxony and the European Union for its technological developments.

Altavo is a medical device startup based in Dresden, Germany, focused on improving the lives of people who have lost their voice. They leverage machine learning and state-of-the-art sensor technology, specifically non-invasive silent speech technology, to enable individuals, particularly laryngectomy patients, to regain a natural-sounding voice. Their team comprises experts from diverse fields including AI, RF engineering, speech therapy, and regulatory affairs, all driven by a passion for creating impactful technologies that enhance patient quality of life. Altavo is collaborating with universities and has received grants from the State of Saxony and the European Union for its technological developments.
Sector: Medical devices / speech rehabilitation
Product: Non-invasive silent-speech / artificial-voice prosthetics using RF/radar sensing + deep learning
Founded: February 2021
Headquarters: Dresden, Germany
Employees: Approximately 13
Recent funding: Series A closed Feb 2024; total funding reported as 5,400,000 USD
Speech rehabilitation for voiceless or aphonic patients (initial focus: laryngectomy patients).
2021
Medical devices / Health care
Syndicate included Novalis Biotech, High-Tech Gründerfonds, TUDAG (TU Dresden AG), Saxonia Systems Holding, TGFS, and bm|t per company disclosures.